Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marsh & Mclennan Companies (MRSH) Gains from Investment Securities (2016 - 2025)

Marsh & Mclennan Companies (MRSH) has disclosed Gains from Investment Securities for 17 consecutive years, with -$14.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Gains from Investment Securities fell 109.09% year-over-year to -$14.0 million, compared with a TTM value of $59.0 million through Jun 2025, up 9.26%, and an annual FY2025 reading of $13.0 million, down 94.01% over the prior year.
  • Gains from Investment Securities was -$14.0 million for Q2 2025 at Marsh & Mclennan Companies, down from $29.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $198.0 million in Q4 2022 and bottomed at -$128.0 million in Q3 2024.
  • Average Gains from Investment Securities over 5 years is $25.1 million, with a median of -$4.0 million recorded in 2021.
  • The sharpest move saw Gains from Investment Securities soared 5050.0% in 2022, then tumbled 1180.0% in 2024.
  • Year by year, Gains from Investment Securities stood at -$4.0 million in 2021, then skyrocketed by 5050.0% to $198.0 million in 2022, then tumbled by 155.05% to -$109.0 million in 2023, then skyrocketed by 257.8% to $172.0 million in 2024, then tumbled by 108.14% to -$14.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for MRSH at -$14.0 million in Q2 2025, $29.0 million in Q1 2025, and $172.0 million in Q4 2024.